Related Experiment Video
Updated: Jun 25, 2026
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Structure-based approaches to antibiotic drug discovery.
1Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.
Current Protocols in Microbiology
|February 24, 2009
Summary
Antimicrobial resistance is a growing threat. New drug discovery strategies leverage structural genomics and computational biology to identify novel microbial targets and design innovative antimicrobial drugs.
Area of Science:
- Microbiology
- Drug Discovery
- Computational Biology
Background:
- Antimicrobial development has advanced significantly over the last century.
- Increasing antimicrobial production capacity is paralleled by the persistent threat of resistance.
- Combating antimicrobial resistance requires novel approaches to drug discovery.
Purpose of the Study:
- To outline and discuss current strategies for antimicrobial drug discovery.
- To highlight the role of structural genomics in identifying new microbial targets.
- To emphasize the utility of computational biology tools in accelerating antimicrobial discovery.
Main Methods:
- Identifying novel microbial protein targets through structural genomics.
- Utilizing computational biology tools for enhanced antimicrobial discovery.
- Employing virtual ligand screening, pocket identification, and compound optimization.
Main Results:
- Structural genomics enables rapid discovery of novel microbial protein targets.
- Computational biology tools significantly improve the speed and reliability of antimicrobial discovery.
- The outlined process integrates target identification with drug design strategies.
Conclusions:
- Two primary avenues for combating antimicrobial resistance are pursued: novel target identification and innovative drug design.
- Modern scientific advancements in structural genomics and computational biology are crucial for effective antimicrobial discovery.
- The integrated approach discussed offers a robust framework for developing new antimicrobials to address resistance.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...